Furiex Pharmaceuticals, Inc. (FURX) Stockholders Approve Acquisition By Actavis (ACT); Ukrainian Antimonopoly Committee Clears Proposed Merger
7/2/2014 10:16:09 AM
MORRISVILLE, N.C.--(BUSINESS WIRE)--The stockholders of Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) voted today at a special meeting of stockholders to adopt the previously announced agreement and plan of merger, dated as of April 27, 2014, providing for the merger of Furiex with an entity now controlled by Forest Laboratories, LLC, a subsidiary of Actavis plc (NYSE: ACT). Actavis completed its acquisition of Forest Laboratories, Inc. on July 1, 2014. The votes cast by Furiex’s stockholders in favor of the proposal to adopt the merger agreement represented approximately 79.85% of Furiex’s issued and outstanding common stock entitled to vote as of May 29, 2014, the record date for the special meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by